The authors' response: Propofol and sedation in patients with coronavirus disease 2019
Am J Emerg Med
.
2021 Apr:42:251.
doi: 10.1016/j.ajem.2020.06.022.
Epub 2020 Jun 18.
Authors
Mitsuhito Soh
1
,
Toru Hifumi
2
,
Shutaro Isokawa
1
,
Masato Shimizu
1
,
Norio Otani
1
,
Shinichi Ishimatsu
1
Affiliations
1
Emergency and Critical Care medicine, St. Luke's International Hospital, Tokyo, Japan.
2
Emergency and Critical Care medicine, St. Luke's International Hospital, Tokyo, Japan. Electronic address: hifumitoru@gmail.com.
PMID:
32611498
PMCID:
PMC7299850
DOI:
10.1016/j.ajem.2020.06.022
No abstract available
Keywords:
COVID-19; Neuroleptic malignant syndrome; propofol.
Publication types
Letter
Comment
MeSH terms
COVID-19*
Conscious Sedation
Coronavirus*
Humans
Hypnotics and Sedatives
Propofol*
SARS-CoV-2
Substances
Hypnotics and Sedatives
Propofol